Home > Insider Trading > Filing (0000899243-18-021486)

Filing Details

Accession Number:: 0000899243-18-021486
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-06 19:32:07
Reporting Period:: 2018-08-02

Accepted Time:: 2018-08-06 19:32:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1668397	Medpace Holdings Inc.	MEDP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1622058	J. August Troendle	C/O Medpace Holdings, Inc. 5375 Medpace Way Cincinnati OH 45227	President & Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-08-02	371,795	$59.20	849,621	No	4	S	Direct
Common Stock	Disposition	2018-08-03	203,296	$59.94	646,325	No	4	S	Direct
Common Stock	Disposition	2018-08-06	156,369	$58.51	489,956	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,000	Indirect	By Son
Common Stock	9,145,510	Indirect	By Medpace Investors, LLC

Footnotes

The sales reported in this Form 4 were effected Pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2018.
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.81 to $60.75. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
The reported full price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.87 to $61.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.84 to $59.59. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the shares held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.